News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novozymes A/S (NZYMb.CO) to Acquire Canada Enzyme Firm for $67 Million


1/31/2013 9:51:10 AM

International enzyme technology firm Novozymes is expanding its business by acquiring Canada-based Iogen Corporation in a deal worth some $67 million. The deal was announced early Friday. Earn-outs to Iogen could add another $12.5 million to the deal. Iogen offers a lineup of industrial enzymes known as Iogen Bio-Products. The deal does not include Iogen's bioenergy process technology. “Iogen Bio-Products is a good fit for Novozymes,” says Andrew Fordyce, vice president of Global Enzyme Sales and Customer Solutions at Novozymes. “We get a number of products that complement our existing product portfolio and welcome a talented group of employees who are very good at developing and producing industrial enzymes.”



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES